Faithward Advisors’s Amgen AMGN Stock Holding History

Faithward Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.42M	Buy	132,492 +131,119	+9,550%	+$46.7M	0.92%	32
2025 Q4	$449K	Buy	+1,373	New	+$436K	0.07%	206
2024 Q4	–	Sell	-901	Closed	-$290K	–	255
2024 Q3	$290K	Sell	901 -13	-1%	-$4.25K	0.05%	226
2024 Q2	$286K	Sell	914 -24	-3%	-$7.05K	0.05%	213
2024 Q1	$267K	Buy	+938	New	+$274K	0.05%	213
2023 Q2	–	Sell	-2,130	Closed	-$495K	–	270
2023 Q1	$495K	Buy	+2,130	New	+$523K	0.11%	109

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Faithward Advisors's AMGN Position: Q1 2026 in Review

Faithward Advisors increased its Amgen (AMGN) stake by 9,550% in Q1 2026, buying an estimated $46.7M and bringing the position to 132,492 shares worth $6.42M. The position accounts for 0.92% of the portfolio, ranked #32.

Faithward Advisors first reported a position in AMGN in Q1 2023 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Faithward Advisors held 132,492 shares of Amgen worth $6.42M as of Q1 2026.
Faithward Advisors bought 131,119 Amgen shares in Q1 2026, an estimated $46.7M.
Amgen made up 0.92% of Faithward Advisors's portfolio in Q1 2026, its #32 holding.
Faithward Advisors first reported a position in Amgen in Q1 2023 and has held it in 6 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.